SFC

Chaque semaine nous faisons le tour de la littérature spécialisée en cardiologie et autour de la Covid-19. Vous trouverez ci-dessous les publications, les recommandations, les abstracts, les consensus d'experts, les positions papers et autres articles mettant en avant une information scientifique importante pour votre pratique.

Chères toutes, Chers tous,

Retrouvez ci-dessous la revue sélective de presse sélectionnée tout au long de la semaine.

Amitiés,
Professeur Ariel Cohen
Past-president de la Société Française de Cardiologie

 

L'actualité brûlante en cardiologie vue par les communautés de la SFC

CARDIOLOGIE PÉDIATRIQUE ET CONGÉNITALE

  • Lessons Learned From 10 Years of Preschool Intervention for Health Promotion: JACC State-of-the-Art Review [SCIENCE DIRECT]
  • Reintervention and Survival After Transcatheter Pulmonary Valve Replacement [SCIENCE DIRECT]

CORONAIRES ET INTERVENTIONNEL

  • Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX [AHA]

IMAGERIE CARDIOVASCULAIRE

  • Characterization of Primary Mitral Regurgitation With Flail Leaflet and/or Wall-Impinging Flow [JAAC]
  • Radiogenomics and Artificial Intelligence Approaches Applied to Cardiac Computed Tomography Angiography and Cardiac Magnetic Resonance for Precision Medicine in Coronary Heart Disease: A Systematic Review [AHA]
  • Normal values and reference ranges for left atrial strain by speckle-tracking echocardiography: the Copenhagen City Heart Study [ACADEMIC]
  • Imaging of the left atrium: pathophysiology insights and clinical utility [ACADEMIC]

INSUFFISANCE CARDIAQUE ET CARDIOMYOPATHIES

  • Randomized Trial of Metoprolol in Patients With Obstructive Hypertrophic Cardiomyopathy [JACC]
  • Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial [ACADEMIC]
  • The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy—the IRON-CRT trial [ACADEMIC]
  • Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysis [ACADEMIC]
  • Ventricular Arrhythmias Among Patients With Advanced Heart Failure: A Population‐Based Study [AHA]

RISQUE CARDIOVASCULAIRE

  • Nocebo/drucebo effect in statin-intolerant patients: an attempt at recommendations [ACADEMIC]
  • Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society [ACADEMIC]
  • Impact of a Patient’s Baseline Risk on the Relative Benefit and Harm of a Preventive Treatment Strategy: Applying Trial Results in Clinical Decision Making [AHA]

RYTHMOLOGIE

  • Anterior–Lateral Versus Anterior–Posterior Electrode Position for Cardioverting Atrial Fibrillation [AHA]
  • Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results from the CABANA Trial [AHA]
  • 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation [JACC]
  • Postmortem Interrogation of Cardiac Implantable Electronic Devices: A 15-Year Experience [JACC]
  • AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial [ACADEMIC]
  • Prognostic markers of all-cause mortality in patients with atrial fibrillation: data from the prospective long-term registry of the German Atrial Fibrillation NETwork (AFNET). [ACADEMIC]
  • Periodic Repolarization Dynamics Identifies ICD-responders in Non-ischemic Cardiomyopathy: A DANISH Substudy. [AHA]
  • Driving Restrictions and Early Arrhythmias in Patients Receiving a Secondary Prevention Implantable Cardioverter-Defibrillator (DREAM-ICD-II study). [AHA]

CARDIO-ONCOLOGIE

  • A systematic review and meta-analysis of beta-blockers and renin–angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer [HEART]
  • Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement [HEART]

HTA

  • Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association [AHA]
  • Borderline and Hypertension [AHA

URGENCES - SOINS INTENSIFS

  • Early Hospital Discharge Following PCI for Patients With STEMI [JACC]
  • Early Hospital Discharge Following PCI for Patients With STEMI [SCIENCE DIRECT]

VALVULOPATHIES

  • Staphylococcus Aureus Infective Endocarditis: JACC Patient Pathways [SCIENCE DIRECT]
  • Characterization of Primary Mitral Regurgitation With Flail Leaflet and/or Wall-Impinging Flow [SCIENCE DIRECT]

Cœur et Covid-19 : saison 5

  • Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients [NEJM]
  • Protection against Covid-19 by BNT162b2 Booster across Age Groups [NEJM]
  • BNT162b2 Vaccine Booster and Mortality Due to Covid-19 [NEJM]
  • Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients [NEJM]

JESFC 2022

L'actualité de la SFC et ses communautés


 

Nos suggestions d’actualités

Les actualités Cardio Online

La muvalaplin : nouvel inhibiteur de la lp(a) par voie orale

21 novembre 2024

Pas de supériorité d’un système d’aide à la décision pour optimiser les thérapies hypolipémiantes dans le post SCA

21 novembre 2024

Efficacité et sécurité d’emploi de l’obicetrapib, un nouvel inhibiteur de la CETP

21 novembre 2024

Zerlasiran, encore un nouvel antiLp(a) en développement

21 novembre 2024

L’edoxaban pour la prévention de thrombose valvulaire

20 novembre 2024

22/11/2024
Actualités SFC
Veille bibliographique

La SFC a lu pour vous : Veille bibliographique - 22/11/24

21/11/2024
Actualités Communautés
Newsletter

Newsletter de la SFHTA - Novembre 2024

21/11/2024
Actualités Congrès
Congrès

Impact environnemental de la cardiologie : Participez à notre enquête nationale !